Homologous and Heterologous Boosting of the Chadox1-S1-S COVID-19 Vaccine With the SCB-2019 Vaccine Candidate: A Randomized, Controlled, Phase 2 Study.

Costa Clemens, Sue Ann; Milan, Eveline Pipolo; Sprinz, Eduardo; Neto, José Cerbino; Pacciarini, Filippo; Li, Ping; Chen, Hui Ling; Smolenov, Igor; Pollard, Andrew; Clemens, Ralf

Costa Clemens, Sue Ann; Milan, Eveline Pipolo; Sprinz, Eduardo; Neto, José Cerbino; Pacciarini, Filippo; Li, Ping; Chen, Hui Ling; Smolenov, Igor; Pollard, Andrew; Clemens, Ralf.

Afiliación

Costa Clemens SA; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
Milan EP; Siena University, Siena, Italy.
Sprinz E; Centro de Estudos e Pesquisa em Moléstias Infecciosas Ltda. (CEPCLIN), Natal, Brazil.
Neto JC; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Pacciarini F; D'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Li P; Clover Biopharmaceuticals Inc., Cambridge, Massachusetts, USA.
Chen HL; Clover Biopharmaceuticals Inc., Cambridge, Massachusetts, USA.
Smolenov I; Clover Biopharmaceuticals Inc., Cambridge, Massachusetts, USA.
Pollard A; Clover Biopharmaceuticals Inc., Cambridge, Massachusetts, USA.
Clemens R; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.

Open Forum Infect Dis ; 9(8): ofac418, 2022 Aug.

Article en En | MEDLINE | ID: mdl-36043184

Palabras clave

COVID-19; SCB-2019; booster; chAdOx1-S; heterologous; homologous; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google